According to the latest data from the Hong Kong Stock Exchange, on January 22, Norges Bank increased its holdings in PHARMARON (03759) by 10.25 million shares, with a transaction price of HK$22.82 per share, amounting to a total consideration of approximately HK$234 million. Following this acquisition, its latest shareholding quantity stands at approximately 21.4742 million shares, representing a holding ratio of 6.09%.